Luis Antón-Aparicio

921 total citations
26 papers, 723 citations indexed

About

Luis Antón-Aparicio is a scholar working on Molecular Biology, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Luis Antón-Aparicio has authored 26 papers receiving a total of 723 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 13 papers in Oncology and 11 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Luis Antón-Aparicio's work include Renal cell carcinoma treatment (6 papers), Cancer Cells and Metastasis (6 papers) and MicroRNA in disease regulation (5 papers). Luis Antón-Aparicio is often cited by papers focused on Renal cell carcinoma treatment (6 papers), Cancer Cells and Metastasis (6 papers) and MicroRNA in disease regulation (5 papers). Luis Antón-Aparicio collaborates with scholars based in Spain, United States and Netherlands. Luis Antón-Aparicio's co-authors include Manuel Valladares‐Ayerbes, M. Blanco, Angélica Figueroa, Mar Haz‐Conde, Lourdes Calvo, Isabel Santamarina, María José Lorenzo-Patiño, Margarita Reboredo, María Quindós and Rosario García‐Campelo and has published in prestigious journals such as Journal of Clinical Oncology, International Journal of Molecular Sciences and British Journal of Cancer.

In The Last Decade

Luis Antón-Aparicio

26 papers receiving 708 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Luis Antón-Aparicio Spain	15	473	392	190	175	51	26	723
Yingrong Lai China	17	727 1.5×	449 1.1×	298 1.6×	235 1.3×	61 1.2×	31	1.1k
Andrea Laforme United States	9	432 0.9×	258 0.7×	154 0.8×	118 0.7×	60 1.2×	9	805
Hongtuan Zhang China	17	399 0.8×	210 0.5×	130 0.7×	118 0.7×	54 1.1×	21	623
Ella Liberzon Israel	8	313 0.7×	278 0.7×	111 0.6×	177 1.0×	45 0.9×	9	529
Hiu‐Fung Yuen Hong Kong	17	550 1.2×	167 0.4×	238 1.3×	122 0.7×	60 1.2×	23	792
Preeti Shah United States	15	512 1.1×	228 0.6×	335 1.8×	226 1.3×	40 0.8×	30	827
Tamara Aleksic United Kingdom	15	454 1.0×	219 0.6×	245 1.3×	98 0.6×	50 1.0×	18	786
Keiichi Aomatsu Japan	15	510 1.1×	194 0.5×	254 1.3×	96 0.5×	79 1.5×	23	817
Caterina Mancarella Italy	15	528 1.1×	402 1.0×	122 0.6×	208 1.2×	61 1.2×	29	761
Guoping Ren China	15	250 0.5×	217 0.6×	181 1.0×	314 1.8×	51 1.0×	40	654

Countries citing papers authored by Luis Antón-Aparicio

Since Specialization

Citations

This map shows the geographic impact of Luis Antón-Aparicio's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Luis Antón-Aparicio with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Luis Antón-Aparicio more than expected).

Fields of papers citing papers by Luis Antón-Aparicio

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Luis Antón-Aparicio. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Luis Antón-Aparicio. The network helps show where Luis Antón-Aparicio may publish in the future.

Co-authorship network of co-authors of Luis Antón-Aparicio

This figure shows the co-authorship network connecting the top 25 collaborators of Luis Antón-Aparicio. A scholar is included among the top collaborators of Luis Antón-Aparicio based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Luis Antón-Aparicio. Luis Antón-Aparicio is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Castellano, Daniel, Pablo Maroto, Enrique Espinosa, et al.. (2017). Experience with Sunitinib in metastatic renal cell carcinoma (mRCC) patients: pooled analysis from 3 Spanish observational prospective studies. Expert Opinion on Drug Safety. 17(6). 573–579. 3 indexed citations

León‐Mateos, Luis & Luis Antón-Aparicio. (2015). Treatment Of Sunitinib-Induced Hypertension In Solid Tumors By Nitric Oxid Donors. Redox Biology. 5. 422–422. 2 indexed citations

Antolín, Silvia, Lourdes Calvo, M. Blanco, et al.. (2015). Circulating miR-200c and miR-141 and outcomes in patients with breast cancer. BMC Cancer. 15(1). 297–297. 78 indexed citations

Antón-Aparicio, Luis, et al.. (2014). MicroARN circulantes en sangre de pacientes con cáncer de próstata. Actas Urológicas Españolas. 38(10). 633–639. 36 indexed citations

Blanco, M., Margarita Reboredo, Mar Haz‐Conde, et al.. (2014). Circulating Levels of GDF15, MMP7 and miR-200c as a Poor Prognostic Signature in Gastric Cancer. Future Oncology. 10(7). 1187–1202. 41 indexed citations

Anido, Urbano, O. Fernández-Calvo, Sergio Vázquez‐Estévez, et al.. (2013). Comprehensive overview of the efficacy and safety of sorafenib in advanced or metastatic renal cell carcinoma after a first tyrosine kinase inhibitor. Clinical & Translational Oncology. 15(6). 425–433. 11 indexed citations

Grande, Enrique, et al.. (2012). A Primary Signet Ring Cell Carcinoma of the Prostate With Bone Metastasis With Impressive Response to FOLFOX and Cetuximab. Clinical Genitourinary Cancer. 10(3). 199–201. 13 indexed citations

Gámez‐Pozo, Angelo, Luis Antón-Aparicio, Pablo Borrega, et al.. (2012). MicroRNA Expression Profiling of Peripheral Blood Samples Predicts Resistance to First-line Sunitinib in Advanced Renal Cell Carcinoma Patients. Neoplasia. 14(12). 1144–IN14. 57 indexed citations

Valladares‐Ayerbes, Manuel, Margarita Reboredo, María José Lorenzo-Patiño, et al.. (2012). Circulating miR-200c as a diagnostic and prognostic biomarker for gastric cancer. Journal of Translational Medicine. 10(1). 186–186. 134 indexed citations

10.

Valladares‐Ayerbes, Manuel, M. Blanco, Mar Haz‐Conde, et al.. (2012). Serum levels of macrophage inhibitory cytokine-1 (MIC1) and matrix metallopeptidase-7 (MMP7) as diagnostic and prognostic markers in gastric cancer (GC) patients (pts).. Journal of Clinical Oncology. 30(15_suppl). e14595–e14595. 1 indexed citations

11.

Grande, Enrique, Jaume Capdevila, Jorge Barriuso, Luis Antón-Aparicio, & Daniel Castellano. (2011). Gastroenteropancreatic neuroendocrine tumor cancer stem cells: do they exist?. Cancer and Metastasis Reviews. 31(1-2). 47–53. 13 indexed citations

12.

Castellano, Daniel, J.L. González-Larriba, Luis Antón-Aparicio, et al.. (2011). Experience in the use of sunitinib given as a single agent in metastatic chemoresistant and castration-resistant prostate cancer patients. Expert Opinion on Pharmacotherapy. 12(16). 2433–2439. 4 indexed citations

13.

Blanco, M., et al.. (2011). New Insights into Molecular Mechanisms of Sunitinib-Associated Side Effects. Molecular Cancer Therapeutics. 10(12). 2215–2223. 93 indexed citations

14.

León‐Mateos, Luis, Sergio Vázquez‐Estévez, Martín Lázaro-Quintela, et al.. (2010). Molecular basis of hypertension side effects induced by sunitinib. Anti-Cancer Drugs. 22(1). 1–8. 28 indexed citations

15.

García‐Campelo, Rosario, et al.. (2010). Renal cell carcinoma: complete pathological response in a patient with gastric metastasis of renal cell carcinoma. Anti-Cancer Drugs. 21(Supplement 1). S13–S15. 17 indexed citations

16.

Valladares‐Ayerbes, Manuel, Silvia Díaz‐Prado, Margarita Reboredo, et al.. (2010). Evaluation of Plakophilin-3 mRNA as a Biomarker for Detection of Circulating Tumor Cells in Gastrointestinal Cancer Patients. Cancer Epidemiology Biomarkers & Prevention. 19(6). 1432–1440. 19 indexed citations

17.

Valladares‐Ayerbes, Manuel, Silvia Díaz‐Prado, Daniel Ayude, et al.. (2009). Diagnostic accuracy of small breast epithelial mucin mRNA as a marker for bone marrow micrometastasis in breast cancer: a pilot study. Journal of Cancer Research and Clinical Oncology. 135(9). 1185–1195. 16 indexed citations

18.

Valladares‐Ayerbes, Manuel, Silvia Díaz‐Prado, Vanessa Médina, et al.. (2008). Bioinformatics approach to mRNA markers discovery for detection of circulating tumor cells in patients with gastrointestinal cancer. Cancer Detection and Prevention. 32(3). 236–250. 28 indexed citations

19.

Feliú, Jaime, Carlos García Girón, Emilio Fonseca, et al.. (2004). Phase II study of UFT and oxaliplatin in first-line treatment of advanced colorectal cancer. British Journal of Cancer. 91(10). 1758–1762. 16 indexed citations

20.

Castro, Javier de, Carlos García Girón, E. Fonseca, et al.. (2004). A combination of oxaliplatin and UFT-l,-leucovorin as first line treatment in advanced colorectal cancer. An ONCOPAZ phase II study. Journal of Clinical Oncology. 22(14_suppl). 3726–3726. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact